Markéta Kalinová

Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometry

Jan Trka, Markéta Kalinová, O Hrušák et al. · Leukemia · 2002 · 119 citations

Residual Disease Detection, Disease Status, Wt1 Gene Expression +11

Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring

Ludmila Boublíková, Markéta Kalinová, Jacqueline Ryan et al. · Leukemia · 2005 · 101 citations

Hematological Malignancy, Tumor Biology, Medicine +9

TEL/AML1 positivity in childhood ALL: average or better prognosis?

Jan Zuna, Ondřej Hrušák, Markéta Kalinová et al. · Leukemia · 1999 · 63 citations

Pediatric Epidemiology, Genetic Disorder, Pediatrics +3

Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study

André Willasch, Bernd Gruhn, Tiziana Coliva et al. · Leukemia · 2009 · 60 citations · Full text

Genetic Disorder, Medicine, Genetics +11

Upregulation of asparagine synthetase fails to avert cell cycle arrest induced by L-asparaginase in TEL/AML1-positive leukaemic cells

Ondřej Krejčí, Júlia Starková, B Otová et al. · Leukemia · 2004 · 53 citations

Signal Transduction, Cell Regulation, Cell Division +9